✦ LIBER ✦

166 A phase I dose-escalation study of anti-a5β1 integrin monoclonal antibody (M200) in patients with refractory solid tumors

✍ Scribed by A. Ricart; G. Liu; A. Tolcher; G. Schwartz; J. Harris; R. Stagg; E. Rowinsky; G. Wilding

Book ID: 118621349
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 297 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)80174-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 1, open-label, dose-escalation s

A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors

✍ von Mehren, Margaret; Britten, Carolyn D.; Pieslor, Peter; Saville, Wayne; Vasso 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 229 KB

1227 A phase 1, dose-escalation study of

1227 A phase 1, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in patients with relapsed or refractory solid tumours

✍ M. von Mehren; C. Britten; P. Piesolor; K. Balogh; A. Bartok; S. Harris; X. Li; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

372 A phase I dose-escalation study of t

372 A phase I dose-escalation study of the fully human monoclonal antibody MNRP1685A (anti-NRP1) administered intravenously to patients with advanced solid tumors

✍ C. Weekes; P. Hedge; Y. Xin; R. Yu; H. Xiang; L. Gore; M. Beeram; R. Brachmann; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

A phase I study of the human monoclonal

A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors

✍ Weekes, Colin D.; Beeram, Muralidhar; Tolcher, Anthony W.; Papadopoulos, Kyriako 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 387 KB

621 A Phase I Dose-escalation Study of M

621 A Phase I Dose-escalation Study of MFGR1877S, a Human Monoclonal Anti-fibroblast Growth Factor Receptor 3 (FGFR3) Antibody, in Patients (pts) with Advanced Solid Tumors

✍ ODonnell, P.; Goldman, J.W.; Gordon, M.S.; Shih, K.; Choi, Y.J.; Lu, D.; Kabbara 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Phase I Dose-Escalation and Pharmacokine

Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors

✍ Demetri, G. D.; Lo Russo, P.; MacPherson, I. R.J.; Wang, D.; Morgan, J. A.; Brun 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 238 KB